Exploratory study of an anti-PD-L1/TGF-β antibody, TQB2858, in patients with refractory or recurrent osteosarcoma and alveolar soft part sarcoma: a report from Chinese sarcoma study group (TQB2858-Ib-02)

Lu Xie(Peking University), Wei Guo(Peking University)
BMC Cancer
September 15, 2023
Cited by 12


Related Papers